Holen Sie sich die Stockscreener-App
20.07
1.72%
0.34
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BAX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$19.73
Offen:
$19.8
24-Stunden-Volumen:
7.30M
Relative Volume:
0.84
Marktkapitalisierung:
$10.32B
Einnahmen:
$10.89B
Nettoeinkommen (Verlust:
$-241.00M
KGV:
-75.56
EPS:
-0.2656
Netto-Cashflow:
$340.00M
1W Leistung:
+1.16%
1M Leistung:
+3.99%
6M Leistung:
-28.45%
1J Leistung:
-39.37%
1-Tages-Spanne:
$19.61
$20.19
1-Wochen-Bereich:
$19.23
$20.19
52-Wochen-Spanne:
$17.40
$37.74
Baxter International Inc Stock (BAX) Company Profile
Firmenname
Baxter International Inc
Sektor
Telefon
(224) 948-2000
Adresse
ONE BAXTER PARKWAY, DEERFIELD, IL
Vergleichen Sie BAX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
20.07 | 10.14B | 10.89B | -241.00M | 340.00M | -0.2656 |
|
ISRG
Intuitive Surgical Inc
|
504.22 | 179.92B | 10.06B | 2.88B | 2.27B | 7.8807 |
|
BDX
Becton Dickinson Co
|
203.48 | 57.29B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
80.98 | 39.86B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
258.31 | 37.60B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
44.20 | 36.39B | 27.43B | 1.27B | 1.01B | 1.5829 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-31 | Herabstufung | Argus | Buy → Hold |
| 2025-08-04 | Herabstufung | Stifel | Buy → Hold |
| 2025-08-01 | Herabstufung | Goldman | Buy → Neutral |
| 2025-02-26 | Fortgesetzt | Goldman | Buy |
| 2025-02-24 | Hochstufung | Argus | Hold → Buy |
| 2025-02-20 | Fortgesetzt | Barclays | Overweight |
| 2024-07-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-05-10 | Herabstufung | TD Cowen | Buy → Hold |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-01-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-12-19 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-12-15 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-12-12 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-06-24 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Herabstufung | Goldman | Neutral → Sell |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-18 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | Bestätigt | Morgan Stanley | Overweight |
| 2022-02-18 | Bestätigt | Raymond James | Outperform |
| 2022-02-18 | Bestätigt | Stifel | Buy |
| 2022-02-18 | Bestätigt | UBS | Neutral |
| 2022-02-18 | Bestätigt | Wells Fargo | Overweight |
| 2022-02-11 | Eingeleitet | Goldman | Neutral |
| 2022-01-07 | Fortgesetzt | Citigroup | Buy |
| 2022-01-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | Hochstufung | Cowen | Market Perform → Outperform |
| 2021-09-03 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-05-25 | Eingeleitet | Barclays | Equal Weight |
| 2021-01-29 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | Herabstufung | UBS | Buy → Neutral |
| 2020-12-15 | Herabstufung | Goldman | Buy → Neutral |
| 2020-10-01 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-09-04 | Herabstufung | Argus | Buy → Hold |
| 2020-06-24 | Eingeleitet | Oppenheimer | Outperform |
| 2020-03-19 | Hochstufung | Stifel | Hold → Buy |
| 2020-03-18 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-13 | Eingeleitet | Goldman | Buy |
| 2020-01-02 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-12-17 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-01-02 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-01-02 | Hochstufung | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | Hochstufung | Argus | Hold → Buy |
| 2018-10-16 | Eingeleitet | Barclays | Underweight |
| 2018-05-17 | Fortgesetzt | Piper Jaffray | Overweight |
| 2018-02-06 | Bestätigt | Citigroup | Neutral |
| 2018-01-03 | Eingeleitet | Evercore ISI | Outperform |
| 2018-01-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
Alle ansehen
Baxter International Inc Aktie (BAX) Neueste Nachrichten
Greenhaven Associates Inc. Takes Position in Baxter International Inc. $BAX - MarketBeat
The Truth About Baxter International Inc.: Is This ‘Boring’ Stock About To Go Viral? - AD HOC NEWS
Are Wall Street analysts predicting Baxter International stock will climb or sink? - MSN
Baxter Stock Performance & 2025 Outlook: Earnings, Analyst Ratings, Price TargetNews and Statistics - IndexBox
Are financial experts on Wall Street forecasting that Baxter International's stock will rise or fall? - Bitget
Are Wall Street Analysts Predicting Baxter International Stock Will Climb or Sink? - Barchart.com
Elastomeric Infusion Pumps Market worth $1.49 billion by 2030 at 5.3%, says MarketsandMarkets™ - GlobeNewswire Inc.
Reasons to Retain Baxter International Stock in Your Portfolio Now - Yahoo Finance
Jobs Data: Is Baxter International Inc in a long term uptrend2025 Dividend Review & Fast Gain Stock Trading Tips - baoquankhu1.vn
Baxter’s Strategic Pivot Faces Key Test with Upcoming Earnings - AD HOC NEWS
Baxter declares $0.01 dividend - MSN
Baxter International Inc. $BAX Shares Purchased by Cooke & Bieler LP - MarketBeat
Stoneridge Investment Partners LLC Buys Shares of 93,458 Baxter International Inc. $BAX - MarketBeat
Assessing Baxter International (BAX) Valuation After Dynamo Series Stretcher Launch At J.P. Morgan Healthcare Conference - Sahm
Baxter International Inc. Stock Underperforms Friday When Compared To Competitors - 富途牛牛
Baxter International Inc. (NYSE:BAX) Receives Consensus Rating of "Reduce" from Analysts - MarketBeat
Baxter International Inc. Stock: Hidden Health-Care Giant or Total Snooze Buy? - AD HOC NEWS
Baxter International (NYSE:BAX) Stock Rating Lowered by Zacks Research - MarketBeat
Baxter International Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains - 富途资讯
FOMO Trade: Is Baxter International Inc stock risky to hold nowJuly 2025 Fed Impact & Daily Price Action Insights - baoquankhu1.vn
Baxter to Host Fourth-Quarter 2025 Financial Results Conference Call for Investors - marketscreener.com
What you need to know ahead of Baxter International's earnings release - MSN
Aug Chart Watch: Is Baxter International Inc in a long term uptrend2025 Valuation Update & Safe Entry Zone Tips - baoquankhu1.vn
Did Baxter’s New Dynamo Smart Stretcher Launch Just Shift Baxter International's (BAX) Investment Narrative? - Yahoo Finance
Baxter's Room Temperature HEMOPATCH Sealing Hemostat Gains Momentum in Australia and New Zealand - PR Newswire
Baxter International: Transition Year With No Immediate Catalysts (NYSE:BAX) - Seeking Alpha
Assessing Baxter International (BAX) Valuation After Mixed Short And Long Term Shareholder Returns - Yahoo Finance
How Recent Analyst Shifts Are Rewriting The Baxter International (BAX) Investment Story - Yahoo Finance
Big Picture: Will Baxter International Inc be affected by tariffsJuly 2025 Update & High Conviction Trade Alerts - baoquankhu1.vn
Sentiment Review: Is SEAT a top pick in the sectorQuarterly Market Summary & Reliable Price Breakout Alerts - baoquankhu1.vn
Baxter International Stock: Quiet Turnaround Play Or Value Trap In Healthcare Tech? - AD HOC NEWS
What To Be Aware Of Before Baxter International Announces Its Earnings - Bitget
Baxter International Inc. (BAX) Stock Analysis: Exploring a 15% Potential Upside Amidst Strategic Global Operations - directorstalkinterviews.com
Palmetto Grain Brokerage - Palmetto Grain Brokerage
What You Need To Know Ahead of Baxter International's Earnings Release - Barchart.com
Sodium Chloride Injections Market, Global Forecast 2026-2032 - GlobeNewswire Inc.
The Bottom Fishing ClubBaxter: Defensive Pick, Restructuring And Paying Down Debt (BAX) - Seeking Alpha
Baxter International (NYSE:BAX) Upgraded to "Buy" at Wall Street Zen - MarketBeat
Baxter International (BAX) Faces Weak EPS Revision Grades - GuruFocus
Goldman Sachs Adjusts Price Target on Baxter International to $21 From $23, Maintains Neutral Rating - marketscreener.com
Lobbying Update: $60,000 of BAXTER HEALTHCARE CORPORATION lobbying was just disclosed - Quiver Quantitative
Baxter Unveils Dynamo Smart Stretcher to Improve Hospital Safety - The Globe and Mail
Manning & Napier Advisors LLC Sells 51,029 Shares of Baxter International Inc. $BAX - MarketBeat
Baxter introduces new hospital stretcher - MassDevice
Baxter International Inc. Stock Underperforms Tuesday When Compared To Competitors - 富途牛牛
Baxter CEO outlines plan to slash debt, boost pipeline in 2026 - chicagobusiness.com
Baxter International Inc. Introduces the Dynamo Series, a New Smart Stretcher to Help Address Common Challenges in HospitalSettings - marketscreener.com
BaxterDynamo series is now available for order in the U.S. and is expected to be available during the first half of 2026 - marketscreener.com
Baxter Introduces the Dynamo Series, a New Smart Stretcher to Help Address Common Challenges in Hospital Settings - rutlandherald.com
Baxter Introduces the Dynamo Series, A New Smart Stretcher to Help Address Common Challenges in Hospital Settings - Baxter
Does Baxter International (BAX) Now Look Fairly Priced After Multi‑Year Share Price Slide - Yahoo Finance
Finanzdaten der Baxter International Inc-Aktie (BAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.66%
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):